Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
Upcoming Talks
Uncovering structural determinants of peptide recognition by public and private T-cell receptors; How ageing shapes influenza-specific CD8+ T cell responses
Friday, 01 May 2026, 9.15am to 10.15am
Global stability and persistence for reaction systems and for generalized Lotka-Volterra systems
Friday, 01 May 2026, 11am to 12pm
Direct-to-Consumer Medical Testing: Exploring Opportunities & Challenges
Tuesday, 05 May 2026, 9.30am to 5.30pm
Connect@CHG Genomics Data Forum: "Genetic determinants of iron status, malaria and bacteremia susceptibility in African children"
Tuesday, 05 May 2026, 10am to 10.30am
Internal state modulation of visual circuits in the mouse and human is driven by pupillary kinetics
Tuesday, 05 May 2026, 12pm to 1pm
Latest publications
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.
Journal article
van Niekerk L. et al, (2026), MAbs, 18
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.
Journal article
Schulz A. et al, (2026), MAbs, 18
Spatio-temporal eco-evolutionary dynamics of prey-predator systems with defended and undefended prey
Preprint
Roy S. et al, (2026)